NASDAQ
Astellas Pharma Inc. (ALPMY) has a free cash flow growth of 219.43% as of Friday, May 29, 2026. This represents a 24.91% increase compared to its 12-month average of 175.67%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.